Literature DB >> 10229822

Antigen-specific T cell activation and proliferation during oral tolerance induction.

J Sun1, B Dirden-Kramer, K Ito, P B Ernst, N Van Houten.   

Abstract

One of several routes of achieving immunologic tolerance is through functional inactivation of Ag-specific T cells. Oral administration of Ag can allow survival of the Ag-specific T cells that are functionally anergic. The aim of this study was to investigate whether functional inactivation of Ag-specific T cells is directed through an activation process and to further define the differentiative pathways and functional characteristics of anergic T cells. Mice were transplanted with OVA-specific TCR-transgenic T cells and either fed OVA or immunized s.c. with the OVA peptide 323-339 in CFA. OVA-specific T cells from OVA-fed mice were unresponsive to restimulation in vitro within 48-72 h after treatment. In vivo, however, T cell proliferation was detected by 5, 6-carboxy-succinimidyl-fluoresceine-ester intensity changes in OVA-specific T cells. The mesenteric lymph nodes (LNs) from OVA-fed mice more frequently contained OVA-specific dividing cells in vivo than those in the peripheral LNs, and the reciprocal was observed following s.c. immunization of the OVA peptide in CFA. The induction of anergy in OVA-fed mice was accompanied by rapid up-regulation of CD69 and CTLA-4, later down-regulation of CD45RB on OVA-specific T cells, and a marked decrease in T cell secretion of IL-2, IL-10, and IFN-gamma after OVA restimulation in vitro. Results from this study indicate that the inductive phase of oral tolerance is preceded by Ag-specific T cell activation in vivo, proliferation in the regional draining LNs, and differentiation into a memory-like state. These results indicate that Ag-directed differentiation occurs as a part of T cell tolerance through anergy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229822

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells.

Authors:  A George-Chandy; K Eriksson; M Lebens; I Nordström; E Schön; J Holmgren
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

Review 2.  Oral tolerance of food.

Authors:  Steve Stanley
Journal:  Curr Allergy Asthma Rep       Date:  2002-01       Impact factor: 4.806

3.  T-cell activation occurs simultaneously in local and peripheral lymphoid tissue following oral administration of a range of doses of immunogenic or tolerogenic antigen although tolerized T cells display a defect in cell division.

Authors:  Karen M Smith; Joanne M Davidson; Paul Garside
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

Review 4.  Getting to the guts of immune regulation.

Authors:  Janine Bilsborough; Joanne L Viney
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

5.  NKT cells play critical roles in the induction of oral tolerance by inducing regulatory T cells producing IL-10 and transforming growth factor beta, and by clonally deleting antigen-specific T cells.

Authors:  Hyun Jung Kim; Su Jin Hwang; Byoung Kwon Kim; Kyeong Cheon Jung; Doo Hyun Chung
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

6.  Oral-tolerization Prevents Immune Responses and Improves Transgene Persistence Following Gene Transfer Mediated by Adeno-associated Viral Vector.

Authors:  Romain Hardet; Benjamin Chevalier; Léa Dupaty; Yassine Naïmi; Gaëtan Riou; Laurent Drouot; Laetitia Jean; Anna Salvetti; Olivier Boyer; Sahil Adriouch
Journal:  Mol Ther       Date:  2015-08-12       Impact factor: 11.454

7.  T cell-mediated oral tolerance is intact in germ-free mice.

Authors:  K L W Walton; J A Galanko; R Balfour Sartor; N C Fisher
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

8.  Th2 polarization enhanced by oral administration of higher doses of antigen.

Authors:  M Hashiguchi; S Hachimura; A Ametani; S Kaminogawa
Journal:  Cytotechnology       Date:  2000-07       Impact factor: 2.058

9.  Ability of the polysaccharide chitosan to inhibit proliferation of CD4+ lymphocytes from mucosal inductive sites, in vitro and in vivo.

Authors:  C Porporatto; M M Canali; I D Bianco; S G Correa
Journal:  Cell Prolif       Date:  2009-08-17       Impact factor: 6.831

10.  Characterization of CD4+ T-cell-dendritic cell interactions during secondary antigen exposure in tolerance and priming.

Authors:  Catherine M Rush; Owain R Millington; Sharon Hutchison; Karen Bryson; James M Brewer; Paul Garside
Journal:  Immunology       Date:  2009-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.